Evidence map›Paper›PMID 30908940›Full record

ReviewAmerican journal of respiratory and critical care medicine2019

Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.

Margaret F Ragland, Christopher J Benway, Sharon M Lutz, Russell P Bowler, Julian Hecker, John E Hokanson, James D Crapo, Peter J Castaldi, Dawn L DeMeo, Craig P Hersh and 5 more

Abstract readReview
In one paragraph

Review in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Annals of medicine · 2025
    Article
  10. Association ofAnnals of medicine · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Breathing new life into the study of COPD with genes identified from genome-wide association studies.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Margaret F RaglandDivision of Pulmonary Sciences and Critical Care Medicine, School of Medicine, and.
Christopher J BenwayChanning Division of Network Medicine and.ORCID 0000-0002-8856-0146
Sharon M LutzDepartment of Biostatistics and.
Russell P BowlerNational Jewish Health, Denver, Colorado.
Julian HeckerHarvard T. H. Chan School of Public Health, Boston, Massachusetts; and.
John E HokansonDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.
James D CrapoNational Jewish Health, Denver, Colorado.
Peter J CastaldiChanning Division of Network Medicine and.
Dawn L DeMeoChanning Division of Network Medicine and.
Craig P HershChanning Division of Network Medicine and.ORCID 0000-0002-1342-4334
Brian D HobbsChanning Division of Network Medicine and.ORCID 0000-0001-9564-0745
Christoph LangeHarvard T. H. Chan School of Public Health, Boston, Massachusetts; and.
Terri H BeatyJohns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Michael H ChoChanning Division of Network Medicine and.
Edwin K SilvermanChanning Division of Network Medicine and.ORCID 0000-0002-3641-3822

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASEST32HL007427 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DAWN L DEMEO, Edwin K Silverman · 1985 to 2026
$13.6M
Systems Biology of Airway DiseaseP01HL132825 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2016 to 2020
$12.6M
Multi-omic Subtyping of Chronic Obstructive Pulmonary DiseaseK08HL136928 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HOBBS, BRIAN DANIEL · 2017 to 2021
$864k
NHLBI NIH HHS K08 HL136928NHLBI NIH HHS P01 HL132825NHLBI NIH HHS R01 HL089897NHLBI NIH HHS T32 HL007427NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a common and progressive disease that is influenced by both genetic and environmental factors. For many years, knowledge of the genetic basis of COPD was limited to Mendelian syndromes, such as alpha-1 antitrypsin deficiency and cutis laxa, caused by rare genetic variants. Over the past decade, the proliferation of genome-wide association studies, the accessibility of whole-genome sequencing, and the development of novel methods for analyzing genetic variation data have led to a substantial increase in the understanding of genetic variants that play a role in COPD susceptibility and COPD-related phenotypes. COPDGene (Genetic Epidemiology of COPD), a multicenter, longitudinal study of over 10,000 current and former cigarette smokers, has been pivotal to these breakthroughs in understanding the genetic basis of COPD. To date, over 20 genetic loci have been convincingly associated with COPD affection status, with additional loci demonstrating association with COPD-related phenotypes such as emphysema, chronic bronchitis, and hypoxemia. In this review, we discuss the contributions of the COPDGene study to the discovery of these genetic associations as well as the ongoing genetic investigations of COPD subtypes, protein biomarkers, and post-genome-wide association study analysis.

Indexed as

Genetic Predisposition to DiseaseAgedAged, 80 and overBiomarkersFemaleGenome-Wide Association StudyHumansLongitudinal StudiesMaleMiddle AgedPhenotypePolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveRisk AssessmentBiomarkerschronic obstructive pulmonary diseaseepidemiologygenetics

Identifiers

PMID30908940
PMCPMC6775891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.